Telehealth Compliance Training | Licensure, Credentialing & Consent
Advance your expertise with telehealth training designed to help healthcare professionals deliver compliant, secure, and legally sound remote care.
Telehealth addiction treatment fraud happens when a virtual substance use disorder provider bills federal healthcare programs for care it never delivered, pays for patient referrals, or prescribes controlled substances without a real clinical evaluation.
Telehealth addiction treatment fraud happens when a virtual substance use disorder provider bills federal healthcare programs for care it never delivered, pays for patient referrals, or prescribes controlled substances without a real clinical evaluation. A telehealth addiction treatment whistleblower is the person who reports this conduct — a clinician, a billing employee, a contractor, or a patient. The False Claims Act protects this person from retaliation. The Drug Enforcement Administration and the Department of Justice actively investigate this conduct as a national enforcement priority. In November 2025, a federal jury convicted the founder and the clinical president of Done Global on charges tied to telemedicine prescribing — the first criminal drug distribution case of its kind. That verdict signals what regulators expect from every virtual provider operating today.
A telehealth addiction treatment whistleblower is an individual who reports fraudulent or illegal conduct inside a virtual substance use disorder program to a government agency. This person flags conduct such as billing Medicaid for counseling sessions that never happened, paying patient brokers for referrals, or prescribing buprenorphine and other controlled substances without a real clinical evaluation.
The whistleblower does not need to be a doctor or executive. Nurse practitioners, intake coordinators, billing staff, marketing contractors, and even patients have filed successful reports. The Department of Justice's Health Care Fraud Unit and the Drug Enforcement Administration both rely on insider reports to build telehealth fraud cases, because virtual visit records and billing codes are not visible to regulators until someone flags them.
The legal mechanism most telehealth whistleblowers use is the qui tam provision of the False Claims Act. This provision lets a private individual file a lawsuit on the government's behalf and recover a share of whatever the government collects.
Advance your expertise with telehealth training designed to help healthcare professionals deliver compliant, secure, and legally sound remote care.
Regulators are paying more attention to telehealth fraud because virtual prescribing volume exploded after the pandemic, and enforcement data now shows the cost. The 2025 National Health Care Fraud Takedown charged 324 defendants, including 96 licensed medical professionals, in connection with $14.6 billion in alleged fraud—the largest coordinated healthcare fraud action in Department of Justice history. The Drug Enforcement Administration also opened 928 administrative cases since October 2025 seeking to revoke prescribers' authority to handle controlled substances.
Civil enforcement has grown alongside criminal enforcement. False Claims Act settlements and judgments hit $6.8 billion in fiscal year 2025, the highest total on record, and more than $5.7 billion of that figure came from healthcare matters. Whistleblowers filed 1,297 qui tam lawsuits that year — also a record, and a 32% increase over the previous year's total.
The Department of Justice's Criminal Division explicitly underscored substance use disorder programs and unlawful prescription drug distribution as top enforcement priorities in its corporate and healthcare fraud updates. Telehealth addiction treatment sits squarely inside that priority list, alongside wound care and durable medical equipment schemes.

Telehealth whistleblowers most commonly report four categories of misconduct: phantom billing, kickbacks, unnecessary prescribing, and falsified documentation. Each category has a distinct pattern that regulators look for in claims data.
This is the most direct form of telehealth fraud. A provider bills Medicare or Medicaid for a counseling session, group therapy visit, or medication check that the patient never attended. The Department of Health and Human Services Office of Inspector General has flagged this pattern repeatedly in telehealth fraud alerts, noting that claims data can show a full caseload of "visits" on days when intake records show no patient contact at all.
The federal Anti-Kickback Statute prohibits paying anyone for referring a patient to a healthcare provider when the cost is billed to a federal program. In telehealth addiction treatment, this often looks like a marketing company or "patient broker" who is paid a fee for every patient they route into a virtual program. The HHS-OIG's 2022 Special Fraud Alert specifically named telehealth marketing arrangements as a high-risk pattern, warning that practitioners in these arrangements often have little or no interaction with the patients they are billing for.
A telehealth provider prescribes a controlled substance, buprenorphine product, or piece of durable medical equipment without an individualized clinical evaluation. The Done Global case is the clearest example: prosecutors alleged the company distributed more than 40 million stimulant pills while generating over $100 million in revenue, using a subscription model that prioritized prescription volume over clinical assessment.
A provider bills a higher-cost service code than the one actually delivered or backdates medical records to make a visit appear more thorough than it was. The 2025 National Health Care Fraud Takedown included a case where a hospice operator created falsified, back-dated records to justify billing for services never rendered—the same documentation pattern regulators watch for in telehealth addiction programs.
The False Claims Act is the primary law that protects a telehealth whistleblower from employer retaliation. This law prohibits an employer from firing, demoting, harassing, or otherwise punishing an employee for reporting suspected fraud against a federal healthcare program. A whistleblower who is retaliated against can sue for reinstatement, double back pay, and compensation for litigation costs.
The False Claims Act also rewards whistleblowers financially. A relator who helps the government recover funds typically receives between 15% and 30% of the total recovery, depending on whether the government intervenes in the case and how substantial the whistleblower's evidence was. Since 1986, when Congress substantially strengthened the civil False Claims Act, settlements and judgments have generated more than $85 billion in total recoveries for the federal government, with the vast majority driven by whistleblower-initiated qui tam actions.
State False Claims Acts provide additional protection in many states, since Medicaid-funded addiction treatment claims often involve both federal and state dollars. The Anti-Kickback Statute and the Controlled Substances Act add criminal exposure on top of the civil penalties under the False Claims Act, which is why telehealth fraud cases increasingly involve both DOJ civil attorneys and DOJ criminal prosecutors working the same conduct.

The most direct path to report suspected telehealth fraud is the HHS Office of Inspector General Hotline, which accepts tips by phone, online form, or mail. Callers can remain anonymous. The hotline number is 1-800-HHS-TIPS (1-800-447-8477), and the online complaint form is available at oig.hhs.gov/fraud/report-fraud.
A strong report includes specific details: the name of the telehealth company, the names of individuals involved, dates and patient volumes if known, and a clear narrative of what happened and how the reporter learned about it. The HHS-OIG states that reports with more specific information have a higher chance of triggering a full investigation rather than a referral or closure.
A whistleblower who wants to pursue a financial reward under the False Claims Act, rather than simply submitting a tip, needs to file a qui tam lawsuit through an attorney. This lawsuit must be filed under seal in federal court, and the "first to file" rule means only the first person to report a specific fraud scheme is eligible for a reward. Waiting to gather more evidence can cost a whistleblower their claim if someone else files first.
After a telehealth whistleblower files a qui tam complaint, the case stays under seal while the Department of Justice investigates, and this investigation period often lasts one to three years. During this time, the defendant company does not know the lawsuit exists. DOJ reviews claims data, interviews witnesses, and decides whether to formally intervene in the case.
If DOJ intervenes, the government takes over primary responsibility for litigating the case, and the whistleblower's reward percentage is typically lower — between 15% and 25% of the recovery. If DOJ declines to intervene, the whistleblower can still pursue the case independently through their attorney, and the potential reward rises to between 25% and 30% if the case succeeds.
Hotline tips submitted directly to HHS-OIG, rather than through a qui tam lawsuit, follow a different process. An OIG analyst reviews the complaint, and the case is either closed, referred to another agency, or escalated to a full investigation. HHS-OIG does not provide complainants with status updates during this process.
The most common mistake telehealth addiction treatment organizations make is treating compliance training as a one-time onboarding task rather than an ongoing requirement. The HHS-OIG's General Compliance Program Guidance specifically states that training must be role-specific, meaning a billing employee and a prescribing clinician need different training content, not the same generic session.
Quick Checklist — Warning Signs an Organization Should Address Before They Become Reportable Conduct:
Prescription volume without proportional clinical time. If providers are seeing dozens of patients per hour, individualized assessment is not realistically happening.
Marketing contracts tied to patient volume. Any arrangement that pays a marketer or broker per patient referred is a kickback risk under the Anti-Kickback Statute.
Billing codes that never vary. A caseload where every visit bills the same high-level code, regardless of complexity, is a documented fraud pattern regulators flag.
No independent prescriber review. If non-physician staff are effectively making prescribing decisions without physician oversight, this violates state corporate practice of medicine rules and exposes the organization to federal scrutiny.
Resistance to internal questions. Staff who raise concerns about billing or prescribing patterns and are told to "stay in their lane" are experiencing the exact retaliation pattern the False Claims Act prohibits.
Patient records created after the fact. Documentation completed days after a visit, especially when it conveniently supports a higher billing code, is the upcoding pattern DOJ has prosecuted repeatedly.
The most effective way to reduce whistleblower complaints is to prevent the underlying fraud, not to discourage reporting. Organizations should build internal reporting channels that staff trust, conduct regular claims audits before regulators do, and train every role—clinical, billing, and marketing—on the specific risks tied to their function.
The Department of Justice has stated explicitly that strong compliance programs and timely self-disclosure can reduce penalties, even after misconduct is discovered. Organizations that wait for an HHS-OIG hotline tip or a qui tam lawsuit lose that opportunity entirely.
If your organization is responsible for telehealth addiction treatment compliance, structured training is the most reliable way to reduce regulatory risk and protect both patients and staff. Our Telehealth Compliance Licensure Credentialing And Consent walks teams through real enforcement cases and the correct response at each stage—built for the pace of a working clinical or billing team.